Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Easing the PPE Strain During the Pandemic

During the early days of the pandemic, one of the healthcare community’s challenges was a critical lack of PPE to fight the coronavirus. Ryan Madewell, Director of Environmental Services at Hunt Regional Healthcare for Vanguard Resources, spoke about this problem and how Surfacide’s UV-C solutions helped keep front-line workers and patients safe. Even before…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Easing the PPE Strain During the Pandemic

During the early days of the pandemic, one of the healthcare community’s challenges was a critical lack of PPE to fight the coronavirus. Ryan Madewell, Director of Environmental Services at Hunt Regional Healthcare for Vanguard Resources, spoke about this problem and how Surfacide’s UV-C solutions helped keep front-line workers and patients safe.

Even before hospitals began to fill up with coronavirus-infected patients, Madewell said the challenge was always how to get more PPE to prepare for those patients.

“We began researching how we were going to be able to get through if we weren’t able to get more PPE or if there was a limited supply, so we landed on UV light. We already had the Surfacide. We’ve been happy with our Helios system for the past seven years. Finding another use for it was great,” he said.

Due to the infectious nature of the virus, Madewell said the situation provided a dual challenge. While never transitioning entirely away from patient safety, it became essential to protect healthcare workers and employees from the virus.

“The fact [was] we had a limited amount of specifically N95s, but disinfectants [also] became hard to come by,” Madewell said. “We had to make some changes and readdress what our processes were going to be, and we made sure everybody stayed safe and had what they needed to do their job.”

When the CDC provided guidance saying UV-C could be used in an emergency to reprocess N95 respirators, and Madewell and his team put a plan together to use Surfacide.

“Not long after we started trial runs, and began reprocessing when it was necessary,” Madewell said. “And we’ve been doing it ever since.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA-authorized digital medical devices have grown substantially over two decades, but regulatory databases still can't track them

FDA-authorized digital medical devices have grown substantially over two decades, but regulatory databases still can't track them

A Nature study reveals a significant increase in FDA-authorized digital medical devices over the past two decades. However, the FDA's regulatory databases are still unable to specify which of these devices contain software. This gap points to the need for improved database capabilities to better track digital medical devices.

  • 01FDA-authorized digital medical devices have increased significantly over the last 20 years.
  • 02The current FDA regulatory databases lack the capability to identify devices that include software.

Aug 5, 2026

Leading with Purpose: Dr. David Foster on Faith, Healthcare Leadership, and Physician Collaboration

Dr. David Foster discusses the importance of faith in healthcare leadership and the role of physician collaboration. The conversation emphasizes how values-driven leadership can positively impact patient care. The dialogue also explores the significance of integrating personal beliefs in professional settings.

  • 01Values-driven leadership can significantly enhance patient care.
  • 02Integrating personal beliefs in professional settings can benefit healthcare leadership.
  • 03Collaboration among physicians is crucial for effective healthcare leadership.

Aug 4, 2026

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health VC hits $7.4B in H1 2026 as AI agents, chronic care, and workforce tools capture mega-deal capital

Digital health venture funding reached $7.4B in the first half of 2026, with significant investments in AI agent platforms and chronic care tools. Mega-deals of over $100 million were a key driver of the funding surge.

  • 01Digital health VC funding hit $7.4 billion in the first half of 2026.
  • 02Mega-deals in AI agent platforms and chronic care tools exceeded $100 million.
  • 03AI, chronic care, and workforce tools dominate digital health investments.

Aug 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512